sodium iodide (i131) capsule t 37-7400 mbq hard capsule
curium netherlands b.v. - sodium iodide (131 i) - capsule, hard - 37-7400 megabecquerel(s) - iodine (131i) compounds; sodium iodide (131i)
xofigo
bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.
xofigo
bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.
endolucinbeta
itm medical isotopes gmbh - lutetium (177lu) chloride - radionuclide imaging - therapeutic radiopharmaceuticals - endolucinbeta is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.
endolucinbeta radiopharmaceutical precursor solution 40 gbqml
qt instruments (s) pte ltd - lutetium (177lu) chloride - solution - lutetium (177lu) chloride 40 gbq/ml
lutetium (177lu) chloride billev (previously illuzyce)
billev pharma aps - lutetium (177lu) chloride - radionuclide imaging - therapeutic radiopharmaceuticals - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.
theracap ¹³¹
ge healthcare limited - sodium iodide (131 i) - capsule - sodium iodide (131 i) - therapeutic radiopharmaceuticals
131i-sodium-iodide thyrotop 38-7400 mbq hard capsules capsules hard
institute of isotopes co. ltd. - 131i sodium iodide - capsules hard - 38-7400mbq
meta-iodobenzylguanidine (i-131) injection for therapeutic use
ge healthcare pte. ltd. - meta-iodobenzylguanidine (i-131) - injection - 185-740 mbq/ml - meta-iodobenzylguanidine (i-131) 0.185 - 0.740 gbq/ml
xofigo
bayer ag - radium (223ra) dichloride - prostatic neoplasms - therapeutic radiopharmaceuticals - xofigo is indicated for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.